CC - The Chemours Company
| Previous Close | 27.02 |
| Open | 27.13 |
| Bid | 0.00 x 800 |
| Ask | 0.00 x 1400 |
| Day's Range | 27.03 - 27.78 |
| 52 Week Range | 25.17 - 54.62 |
| Volume | 2,555,634 |
| Avg. Volume | 1,977,725 |
| Market Cap | 4.647B |
| Beta (3Y Monthly) | 2.84 |
| PE Ratio (TTM) | 4.69 |
| EPS (TTM) | 5.80 |
| Earnings Date | Feb 12, 2019 - Feb 18, 2019 |
| Forward Dividend & Yield | 1.00 (3.68%) |
| Ex-Dividend Date | 2018-11-15 |
| 1y Target Est | 45.00 |
- Simply Wall St.•8 days ago
Is There An Opportunity With The Chemours Company’s (NYSE:CC) 31.3% Undervaluation?
In this article I am going to calculate the intrinsic value of The Chemours Company (NYSE:CC) by estimating the company's future cash flows and discounting them to their present value. Read More...
Market Realist•9 days agoTronox Seeks Permission to Present Its Divestiture Plans
On December 4, Tronox (TROX) announced that it filed a motion with the Honorable D. Michael Chappell, the chief administrative law judge, seeking permission to present the proposed divestitures to the FTC (Federal Trade Commission). Tronox’s acquisition of Cristal is pending due to approval from the FTC. If Tronox gets approval from the administrative law judge, it would be able to engage in direct discussions with FTC commissioners.
- Motley Fool•9 days ago
Here's Why The Chemours Company Dropped 13.7% in November
The diversified specialty chemicals producer announced strong third-quarter 2018 earnings. What happened?
- Insider Monkey•10 days ago
Is The Chemours Company (CC) A Good Stock To Buy?
At Insider Monkey we follow around 700 of the best-performing investors and even though many of them lost money in the last couple of months (70% of hedge funds lost money in October whereas S&P 500 ETF lost about 7%), the history teaches us that over the long-run they still manage to beat the market, […]
- Motley Fool•11 days ago
How General Electric Could Get Itself Back on Track
The industrial conglomerate has one appealing option to return to outperformance.
- GuruFocus.com•14 days ago
First Eagle Comments on Chemours
Why it was purchased: The Fund invested in Chemours ( NYSE:CC ) in January 2018. The company, which had spun out of DuPont in 2015, appeared to be a secular growth stock trapped within a commodity chemical company. This year, forty-two percent of Chemours' earnings have come from its fluoroproducts division, which makes the next generation of environmentally friendly refrigerants as well as products that are used in electric vehicles, renewable energy storage and 5G connectivity.
Market Realist•14 days agoVersum Materials Rose 9.8% in November
Versum Materials (VSM), a spin-off company of Air Products and Chemicals (APD), was the second-best performer among specialty chemical companies. Versum Materials gained ~9.8% in November. The company outperformed the S&P 500 (SPY), which gained 1.8%.
- Zacks•20 days ago
Chemours (CC) to Increase Prices of Methylamines Products
Chemours' (CC) latest price hike is likely to support its margins.
- PR Newswire•21 days ago
Chemours Announces Price Increase for Methylamines Products in North America
WILMINGTON, Del. , Nov. 27, 2018 /PRNewswire/ -- The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in titanium technologies, fluoroproducts and chemical ...
- Motley Fool•21 days ago
Is Chemours a Buy?
With shares of the specialty chemicals manufacturer plunging more than 40% so far this year, the stock is certainly much cheaper.
- Associated Press•25 days ago
NC environmental chief: Chemical maker must change its ways
The largest penalty a polluter has paid North Carolina should change the way one of the country's biggest chemical companies makes compounds that the U.S. Environmental Protection Agency said appear dangerous even in small amounts, the state's top environmental official said Friday. A deal announced late Wednesday requires The Chemours Co. to pay the state a $12 million penalty, add $1 million for investigative costs, sharply reduce air emissions of the nonstick compound known as GenX, and spend millions to provide permanent replacement drinking water supplies to neighbors with contaminated water wells. "It will change the way this company operates in the state of North Carolina if they are serious about remaining operational here," state Department of Environmental Quality Michael Regan said Friday.
- Thomson Reuters StreetEvents•last month
Edited Transcript of CC earnings conference call or presentation 2-Nov-18 12:30pm GMT
Q3 2018 Chemours Co Earnings Call
- Market Realist•last month
APD’s Industrial Gases–EMEA Segment: Lowest Margin in Two Years
In the fourth quarter, Air Products and Chemicals’ (APD) Industrial Gases–EMEA segment’s total revenue contribution expanded by 0.7 percentage points YoY (year-over-year) from 23.4% to 24.1%. The segment reported revenues of $554.7 million, which implies YoY revenue growth of 7.8%. In the fourth quarter of 2017, the segment reported revenues of $514.8 million.
- GlobeNewswire•last month
Research Report Identifies Canopy Growth, MSG Networks, ANI Pharmaceuticals, Mistras Group, Rowan Companies, and Chemours with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement
NEW YORK, Nov. 12, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.
- Simply Wall St.•last month
Do You Know What The Chemours Company’s (NYSE:CC) P/E Ratio Means?
This article is for investors who would like to improve their understanding of price to earnings ratios (P/E ratios). We’ll look at The Chemours Company’s (NYSE:CC) P/E ratio and reflect Read More...
- Moody's•last month
E.I. du Pont de Nemours and Company -- Moody's affirms DuPont's A3 ratings, changes outlook to stable
Moody's Investors Service ("Moody's") affirmed the A3 and Prime-2 ratings of E.I. du Pont de Nemours and Company (DuPont) and changed the outlook on the ratings to stable from negative. The action is in response to the company's disclosure of its plan for the balance sheet of DuPont, which is expected to become wholly owned by a new legal entity, Corteva, Inc. On June 1st, 2019, Corteva Inc. (Corteva) is expected to be spun off from DowDuPont, and any existing rated debt of DuPont will become the obligations of Corteva.
Market Realist•last monthDowDuPont’s Material Science Revenues Rose in Q3
DowDuPont’s (DWDP) Material Science segment, which is slated to be spun off and called Dow by the end of Q1 2019, accounted for 61.7% of DWDP’s total revenues in Q3 2018. In Q3 2017, this segment accounted for 59.9% of DWDP’s total revenue, a year-over-year increase of 1.8 percentage points.
Zacks•last monthChemours (CC) Q3 Earnings Beat, Revenues Trail Estimates
Chemours' (CC) Q3 results benefits from strong demand in Fluoroproducts and higher global average selling prices in Titanium Technologies.
- Insider Monkey•2 months ago
Apple, Cirrus Logic, GoPro, and More: Here’s Why These Stocks Are On the Move
It’s another busy day in terms of earnings and news, and not surprisingly, a lot of stocks are on the move. Among the equities moving on news include Apple Inc. (NASDAQ:AAPL), Cirrus Logic Inc. (NASDAQ:CRUS), GoPro Inc. (NASDAQ:GPRO), Adverum Biotechnologies Inc. (NASDAQ:ADVM), and Chemours Co (NYSE:CC). Let’s analyze further. For those of you interested in potentially partly diversifying your portfolio […]
- Zacks•2 months ago
Chemours (CC) Surpasses Q3 Earnings Estimates
Chemours (CC) delivered earnings and revenue surprises of 7.97% and -5.12%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
- Associated Press•2 months ago
Chemours: 3Q Earnings Snapshot
On a per-share basis, the Wilmington, Delaware-based company said it had net income of $1.51. Earnings, adjusted for non-recurring gains, came to $1.49 per share. The results beat Wall Street expectations. ...
- MarketWatch•2 months ago
Teflon maker Chemours stock falls after company's Q3 sales miss
Shares of Chemours Co. were down 8% in the extended session Thursday after the chemical company spun off DuPont reported third-quarter sales below expectations and said it expects fourth-quarter profits on the lower side of its guidance. Chemours said it earned $275 million, or $1.51 a share, in the quarter, compared with $207 million, or $1.08 a share, in the year-ago quarter. Adjusted for one-time items, Chemours earned $271 million, or $1.49 a share, compared with $203 million, or $1.06 a share, a year ago. Revenue rose 3% to $1.63 billion. Analysts polled by FactSet expected Chemours to earn an adjusted $1.42 a share on sales of $1.71 billion. Adjusted profits for the fourth quarter are likely to fall "within the lower half of our original guidance range of $1.70 to $1.85 billion," the company said. Full-year adjusted EPS are seen between $5.10 a share and $5.85 a share. Chemours shares ended the regular trading day up 5.9%.
- PR Newswire•2 months ago
/C O R R E C T I O N -- The Chemours Company/
In the news release, The Chemours Company Reports Third Quarter 2018 Results, Solid Earnings Improvement Across All Segments, issued 01-Nov-2018 by The Chemours Company over PR Newswire, we are advised ...
- Zacks•2 months ago
Chemical Stock Earnings Slated on Nov 1: DWDP, CC, PAH & ICL
Investors should check these chemical stocks before their quarterly results as the industry is expected to sustain the momentum in Q3.
- PR Newswire•2 months ago
Chemours Announces Fourth Quarter Dividend
WILMINGTON, Del. , Oct. 30, 2018 /PRNewswire/ -- The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in titanium technologies, fluoroproducts and chemical ...
